6550--Cepheid Molecular Diagnostic Testing System Reagents and Assays - VISN 6 BPA
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C24625R0009
- Agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) Network Contracting Office 6 has published a Special Notice for a sole-source contract opportunity to acquire Cepheid molecular diagnostic testing system reagents and assays. The VA intends to award a new firm-fixed price Blanket Purchase Agreement (BPA) to Cepheid, the original equipment manufacturer and sole provider of the required Cepheid diagnostic substances, reagents, and test kits. This is a brand-name only requirement to support VA medical center laboratories in the VISN 6 region.
The purpose of this Special Notice is to inform interested parties of the VA's intent to negotiate a new BPA contract with Cepheid. The anticipated contract effective date is December 20, 2024, and interested parties must respond within 3 calendar days to the identified Contract Specialist. Market research has determined these highly specialized items are only available from Cepheid without unacceptable delay or duplication of cost. This is not a request for competitive offers, and no solicitation is available. Respondents must indicate whether they are a large, small, small-disadvantaged, 8(a), or woman-owned business, and whether they are U.S. or foreign-owned.
Notice text
The Department of Veteran Affairs, Veterans Health Administration, Network Contracting Office 6, Hampton VA 23667, intends to negotiate a new VISN BPA, sole source, firm-fixed price contract for the Hampton, Durham, Richmond, Salem, Asheville, Salisbury, and Fayetteville VAMC laboratories and the South Charlotte HCC, Greenville HCC, Fayetteville FHCC, Kernersville HCC, Wilmington WHCC, North Battlefield HCC, and any new HCC laboratory activation to Cepheid (large business) for Cepheid Diagnostic Substances, Reagents, and Test Kits with 41 U.S.C. §3304(a)(1) as implemented by FAR 6.302-1 Only One Responsible Source.
This is not a request for competitive offers and no solicitation is available. Market research has determined that these items are highly specialized, are only available from a single source without an unacceptable delay or duplication of cost and no other type of items will satisfy agency requirements. The Government intends to award the contract with an effective date of 20 December 2024 to Cepheid, 904 Caribbean Dr, Sunnyvale, CA 94089; Unique Entity ID: W6HQTMWB9.
This is a Brand-Name Only requirement for Hampton, Durham, Richmond, Salem, Asheville, Salisbury, and Fayetteville VAMC laboratories and the South Charlotte HCC, Greenville HCC, Fayetteville FHCC, Kernersville HCC, Wilmington WHCC, North Battlefield HCC, and any new HCC laboratory activation. Cepheid is the original equipment manufacturer of the Cepheid GeneXpert Molecular Diagnostic Testing Systems and the sole provider for Cepheid Diagnostic Substance, Reagents, and Test Kits. Cepheid has no authorized distributors to provide the reagents, assay, and test kits for the Cepheid GeneXpert Molecular Diagnostic Testing equipment in use at the VA Medical Center laboratories. No other supplies or services will satisfy agency requirements per FAR 13.106-1(b)(1).
This synopsis announcement is being issued for information purposes only and does not constitute a solicitation or request for competitive proposals. If a firm believes it is capable of meeting the Government's requirement, it may identify its interest and capability to the contract specialist within three (3) calendar days of this publication by contacting Chellry Whittier via e-mail at chellry.whittier@va.gov Telephone inquiries will not be accepted. This announcement closes 18 November 2024 at 15:00 PM EST. Those interested firms must indicate whether they are large, small, small-disadvantaged, 8(a) or woman owned business and whether they are U.S. or foreign owned. Respondents who submit proprietary data shall clearly mark the data with appropriate markings. The Government will not pay for any information submitted as a result of this synopsis. This synopsis shall not be construed as an obligation on the part of the Government to acquire any products or services.
***Reference RFP 36C24625R0009 in all replies***
Files
| File | Type | Posted |
|---|---|---|
| 36C24625R0009.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550--Cepheid Molecular Diagnostic Testing System Reagents and Assays - VISN 6 BPA | Award Notice | |
| This notice | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| 6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ | Veterans Integrated Service Network 5 | No set-aside | |
| 6640--Capillary Electrophoresis | Veterans Integrated Service Network 6 | No set-aside | |
| 7A21--Siemens UniPOC Licenses and Service | VA Technology Acquisition Center | No set-aside | |
| Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC | Veterans Integrated Service Network 20 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity